Xiaoyu Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xiaoyu Zhang has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
Qian Ma
Vascular Biology Center, Medical College of Georgia Augusta University Augusta Georgia USA
3 shared publications- Yuqing Huo
Departments of Ophthalmology, Medicine, and Molecular and Cellular Biology, Baylor College of Medicine
3 shared publications Jiean Xu
Vascular Biology Center, Medical College of Georgia Augusta University Augusta Georgia USA
2 shared publicationsLina Wang
State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Genomics Peking University Shenzhen Graduate School Shenzhen China
2 shared publicationsMei Hong
State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Genomics, School of Chemical Biology and Biotechnology Peking University Shenzhen Graduate School Shenzhen China
2 shared publicationsQiuhua Yang
Vascular Biology Center, Department of Cellular Biology and Anatomy, Medical College of Georgia Augusta University Augusta Georgia USA
2 shared publications
Latest Publications
- Open Access
- 9 August 2022
- Published by Wiley in British Journal of Pharmacology
- Vol. 179 (22) , 5109-5131
Suppression of myeloid PFKFB3‐driven glycolysis protects mice from choroidal neovascularization
Background and Purpose: Pathological angiogenesis is a major cause of irreversible blindness in individuals with neovascular age‐related macular degeneration (nAMD). Macrophages and microglia (MΦ) contribute to aberrant ocular angiogenesis. However, the role of glucose metabolism of MΦ in nAMD is still undefined. Here, we have investigated the involvement of glycolysis, driven by the kinase/phosphatase PFKFB3, in the development of choroidal neovascularization (CNV).Experimental Approach: CNV was induced in mice with laser photocoagulation. Choroid/retinal pigment epithelium (RPE) complexes and MΦ were isolated for analysis by qRT‐PCR, western blot, flow cytometry, immunostaining, metabolic measurements and angiogenesis assays.Key Results: MΦ accumulated within the CNV of murine nAMD models and expressed high levels of glycolysis‐related enzymes and M1/M2 polarization markers. This phenotype of hyper‐glycolytic and activated MΦ was replicated in bone marrow‐derived macrophages stimulated by necrotic RPE in vitro. Myeloid cell‐specific knockout of PFKFB3, a key glycolytic activator, attenuated pathological neovascularization in laser‐induced CNV, which was associated with decreased expression of MΦ polarization markers and pro‐angiogenic factors, along with decreased sprouting of vessels in choroid/RPE complexes. Mechanistically, necrotic RPE increased PFKFB3‐driven glycolysis in macrophages, leading to activation of HIF‐1α/HIF‐2α and NF‐κB, and subsequent induction of M1/M2 markers and pro‐angiogenic cytokines, finally promoting macrophage reprogramming towards an angiogenic phenotype to facilitate development of CNV. The PFKFB3 inhibitor AZ67 also inhibited activation of HIF‐1α/HIF‐2α and NF‐κB signalling and almost completely prevented laser‐induced CNV in mice.Conclusions and Implications: Modulation of PFKFB3‐mediated macrophage glycolysis and activation is a promising strategy for the treatment of nAMD.
- 9 August 2022
- Published by Wiley in British Journal of Pharmacology
- Vol. 179 (22) , 5109-5131
Open AccessSuppression of myeloid PFKFB3‐driven glycolysis protects mice from choroidal neovascularization
Background and Purpose: Pathological angiogenesis is a major cause of irreversible blindness in individuals with neovascular age‐related macular degeneration (nAMD). Macrophages and microglia (MΦ) contribute to aberrant ocular angiogenesis. However, the role of glucose metabolism of MΦ in nAMD is still undefined. Here, we have investigated the involvement of glycolysis, driven by the kinase/phosphatase PFKFB3, in the development of choroidal neovascularization (CNV).Experimental Approach: CNV was induced in mice with laser photocoagulation. Choroid/retinal pigment epithelium (RPE) complexes and MΦ were isolated for analysis by qRT‐PCR, western blot, flow cytometry, immunostaining, metabolic measurements and angiogenesis assays.Key Results: MΦ accumulated within the CNV of murine nAMD models and expressed high levels of glycolysis‐related enzymes and M1/M2 polarization markers. This phenotype of hyper‐glycolytic and activated MΦ was replicated in bone marrow‐derived macrophages stimulated by necrotic RPE in vitro. Myeloid cell‐specific knockout of PFKFB3, a key glycolytic activator, attenuated pathological neovascularization in laser‐induced CNV, which was associated with decreased expression of MΦ polarization markers and pro‐angiogenic factors, along with decreased sprouting of vessels in choroid/RPE complexes. Mechanistically, necrotic RPE increased PFKFB3‐driven glycolysis in macrophages, leading to activation of HIF‐1α/HIF‐2α and NF‐κB, and subsequent induction of M1/M2 markers and pro‐angiogenic cytokines, finally promoting macrophage reprogramming towards an angiogenic phenotype to facilitate development of CNV. The PFKFB3 inhibitor AZ67 also inhibited activation of HIF‐1α/HIF‐2α and NF‐κB signalling and almost completely prevented laser‐induced CNV in mice.Conclusions and Implications: Modulation of PFKFB3‐mediated macrophage glycolysis and activation is a promising strategy for the treatment of nAMD.
- Open Access
- 1 November 2021
- Published by Elsevier in Asian Journal of Surgery
- Vol. 44 (11) , 1398-1399
Emergency thoracic endovascular aortic repair may be an effective way to treat stanford type B aortic dissection combined with severe complications
- 1 November 2021
- Published by Elsevier in Asian Journal of Surgery
- Vol. 44 (11) , 1398-1399
Open AccessEmergency thoracic endovascular aortic repair may be an effective way to treat stanford type B aortic dissection combined with severe complications
- 10 December 2020
- Published by Wiley in British Journal of Pharmacology
- Vol. 178 (5) , 1055-1072
Mice with a specific deficiency of Pfkfb3 in myeloid cells are protected from hypoxia‐induced pulmonary hypertension
Background and Purpose: Macrophage infiltration into the lungs is a characteristic of pulmonary hypertension (PH). Glycolysis is the main metabolic pathway for macrophage activation. However, the effect of macrophage glycolysis on the development of PH remains unknown. We investigated the effect of 6‐phosphofructo‐2‐kinase/fructose‐2,6‐bisphosphatase 3 (PFKBF3), a critical enzyme of macrophage glycolysis, on PH development.Experimental Approach: Lung tissues from PH patients were examined by immunostaining with macrophage markers. PH was induced in Wistar rats with SU5416/hypoxia and in mice with hypoxia. Lungs and macrophages were isolated for analysis by RT‐PCR, western blot, flow cytometry, and immunostaining.Key Results: Expression of glycolytic molecules was increased in circulating peripheral blood mononuclear cells (PBMCs) and lung macrophages of PH patients. These results were also found in lung macrophages of SU5416/hypoxia (Su/Hx)‐induced PH rats and hypoxia‐induced PH mice. PH was ameliorated in myeloid‐specific Pfkfb3‐deficient mice (Pfkfb3ΔMϕ) or mice treated with the PFKFB3 inhibitor 3PO, compared with their controls. Alveolar macrophages of PH Pfkfb3ΔMϕ mice produced lower levels of growth factors and pro‐inflammatory cytokines than those of control mice. Circulating myeloid cells and lung myeloid cells were much fewer in PH Pfkfb3ΔMϕ mice than controls. Mechanistically, overexpression of Hif1a or Hif2a in bone marrow‐derived macrophages (BMDMs) cultured with bone marrow of Pfkfb3ΔMϕ mice restored the decreased expression of pro‐inflammatory cytokines and growth factors.Conclusions and Implications: Myeloid Pfkfb3 deficiency protects mice from PH, thereby suggesting that myeloid PFKFB3 is one of the important targets in the therapeutic effect of PFKFB3 inhibition in PH treatment.
- 10 December 2020
- Published by Wiley in British Journal of Pharmacology
- Vol. 178 (5) , 1055-1072
Mice with a specific deficiency of Pfkfb3 in myeloid cells are protected from hypoxia‐induced pulmonary hypertension
Background and Purpose: Macrophage infiltration into the lungs is a characteristic of pulmonary hypertension (PH). Glycolysis is the main metabolic pathway for macrophage activation. However, the effect of macrophage glycolysis on the development of PH remains unknown. We investigated the effect of 6‐phosphofructo‐2‐kinase/fructose‐2,6‐bisphosphatase 3 (PFKBF3), a critical enzyme of macrophage glycolysis, on PH development.Experimental Approach: Lung tissues from PH patients were examined by immunostaining with macrophage markers. PH was induced in Wistar rats with SU5416/hypoxia and in mice with hypoxia. Lungs and macrophages were isolated for analysis by RT‐PCR, western blot, flow cytometry, and immunostaining.Key Results: Expression of glycolytic molecules was increased in circulating peripheral blood mononuclear cells (PBMCs) and lung macrophages of PH patients. These results were also found in lung macrophages of SU5416/hypoxia (Su/Hx)‐induced PH rats and hypoxia‐induced PH mice. PH was ameliorated in myeloid‐specific Pfkfb3‐deficient mice (Pfkfb3ΔMϕ) or mice treated with the PFKFB3 inhibitor 3PO, compared with their controls. Alveolar macrophages of PH Pfkfb3ΔMϕ mice produced lower levels of growth factors and pro‐inflammatory cytokines than those of control mice. Circulating myeloid cells and lung myeloid cells were much fewer in PH Pfkfb3ΔMϕ mice than controls. Mechanistically, overexpression of Hif1a or Hif2a in bone marrow‐derived macrophages (BMDMs) cultured with bone marrow of Pfkfb3ΔMϕ mice restored the decreased expression of pro‐inflammatory cytokines and growth factors.Conclusions and Implications: Myeloid Pfkfb3 deficiency protects mice from PH, thereby suggesting that myeloid PFKFB3 is one of the important targets in the therapeutic effect of PFKFB3 inhibition in PH treatment.
- 5 August 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 12 (555)
Glycolysis links reciprocal activation of myeloid cells and endothelial cells in the retinal angiogenic niche
Increased glycolysis facilitates reciprocal activation between myeloid cells and endothelial cells in pathological retinal angiogenesis.
- 5 August 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 12 (555)
Glycolysis links reciprocal activation of myeloid cells and endothelial cells in the retinal angiogenic niche
Increased glycolysis facilitates reciprocal activation between myeloid cells and endothelial cells in pathological retinal angiogenesis.
- Open Access
- 24 April 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (17) , 29535
Correction: miR-874 functions as a tumor suppressor by inhibiting angiogenesis through STAT3/VEGF-A pathway in gastric cancer
- 24 April 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (17) , 29535
Open AccessCorrection: miR-874 functions as a tumor suppressor by inhibiting angiogenesis through STAT3/VEGF-A pathway in gastric cancer